市场调查报告书
商品编码
1466033
下一代隐形眼镜和辅助器具视器市场:按产品、按疾病分类 - 全球预测 2024-2030 年Next Generation Contact Lenses & Visual Prostheses Market by Product, Disease - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
下一代隐形眼镜和辅助器具市场规模预计到2023年为2.1471亿美元,2024年达到2.5445亿美元,2030年达到7.1557亿美元,复合年增长率预计为18.76%。
下一代隐形眼镜包括各种先进的功能和材料,增强了传统视力矫正以外的功能。其中包括采用智慧技术设计的隐形眼镜,这些技术可实现互动式视觉覆盖、健康监测感测器、药物输送系统以及透过先进材料和设计来提高舒适度和视力等功能。视觉假体是医疗设备,旨在帮助因视网膜色素变性或老龄化黄斑部病变等疾病而导致视力丧失或视力障碍的人恢復功能性视力。这些设备的工作原理通常是绕过受损的感光器,直接刺激视觉系统的其余功能部分,例如视网膜、视神经和视觉皮层。人口老化的加剧、眼部相关疾病发病率的增加以及对非侵入性医疗设备的需求不断增加正在促进市场扩张。然而,高昂的市场开拓和製造成本以及医疗设备审批的严格监管要求可能会阻碍市场成长。然而,监测健康指标的智慧隐形眼镜开拓、根据患者个体需求製造设备的客製化技术、改善视觉假体功能的 3D 列印技术和人工智慧演算法的市场仍在不断涌现,预计这些整合将创造潜在机会。一代隐形眼镜和视觉假体市场扩张。
主要市场统计 | |
---|---|
基准年[2023] | 21471万美元 |
预测年份 [2024] | 2.5445亿美元 |
预测年份 [2030] | 71557万美元 |
复合年增长率(%) | 18.76% |
产品 治疗性隐形眼镜正迅速应用于术后护理和各种角膜疾病的治疗。
诊断或监测隐形眼镜是先进的眼科设备,旨在非侵入性测量眼压、血糖浓度和泪液成分等生理参数。药物释放型隐形眼镜旨在将药物直接控制释放到眼睛中,为治疗感染疾病、过敏和干眼等眼部疾病提供一种新方法。这些镜片浸有治疗剂,与传统眼药水相比,可提高药物接触时间、增加生物有效性、减少全身性副作用、提高患者依从性和治疗效果。治疗性隐形眼镜旨在治疗和控制眼表疾病和损伤。它为角膜提供保护屏障,促进癒合,并可以输送药物。视觉假体或「仿生眼」旨在帮助因视网膜疾病而严重视力丧失或失明的人恢復视力。这些系统由连接在眼镜上的摄影机、视讯处理单元和电刺激视觉系统的植入组成。皮质植入是一种视觉假体,完全绕过眼球,瞄准大脑视觉皮质。该装置将视觉讯息转换为直接发送到大脑视觉皮质的电刺激模式,目的是恢復因眼球、视神经或皮质前视觉途径受损而丧失视力的人的视觉感知。视神经植入是一种视觉假体,旨在直接刺激视神经,将视觉讯息从视网膜传送到大脑。当视网膜出现故障,但神经和下游视觉途径保持完好时,通常会考虑这种情况。视网膜植入取代退化视网膜细胞的功能,主要用于治疗老龄化黄斑部病变和色素性视网膜炎等视网膜疾病。这些植入捕捉光并将其转化为电讯号,刺激剩余的视网膜细胞并向大脑发送视觉讯息。
用于治疗老龄化黄斑部病变的下一代隐形眼镜和视觉假体的采用持续增长
老龄化黄斑部病变是 50 岁以上族群视力丧失的主要原因。其特征是视网膜中央部分(称为黄斑部)劣化,影响中央视力。有干式和湿式两种渐进式。新一代视觉假体和隐形眼镜正在研究中,它们可以放大剩余视力,向视网膜输送药物以减缓其进展,或结合与视网膜神经迴路连接的微型相机来恢復视力。糖尿病眼科疾病,主要是糖尿病性视网膜病变和糖尿病黄斑部水肿,是由视网膜血管损伤引起的糖尿病併发症。隐形眼镜技术的最新进展包括可以透过泪液监测血糖浓度的镜片,这可能有助于糖尿病管理。青光眼是一组损害视神经的眼科疾病,通常与眼内压升高有关。未经治疗的青光眼会导致不可逆转的视力丧失。带有内建感测器的隐形眼镜已经开发出来,可以连续监测眼压水平,提供一种非侵入性的方法来控制和减缓青光眼的进展。青光眼患者的视觉假体可用于刺激受损视神经以外的视觉途径。色素性视网膜炎是一种影响视网膜的遗传性疾病,导致视力逐渐丧失和夜盲症。在假眼领域,在製造仿生眼植入以取代视网膜退化的光感受器功能方面取得了重大进展。在隐形眼镜方面,研究重点是含有微电子的镜片,以增强可用视力并提供光疗以减缓 RP 的进展。
区域洞察
美洲地区较高的消费者认知度、强劲的经济以及医疗设备的保险覆盖范围促进了市场需求的成长。人们对具有血糖监测和扩增实境(AR) 等先进功能的智慧隐形眼镜的兴趣正在刺激一些新兴企业和研发倡议。此外,人们对先进医疗设备的兴趣与日俱增,私人公司和学术机构的倡议正在推动美洲视觉修復和增强眼科设备的创新解决方案。在欧盟国家,由于与数位萤幕相关的活动增加和人口老化,对高级隐形眼镜的需求正在增加。医疗设备法规 (MDR) 等监管指令形成了业界标准。由欧盟研究和创新框架计划资助的正在进行的计划表明了我们对尖端眼科技术的承诺。在中东,这些先进的医疗设备正在逐渐被采用,并且非常注重奢华和品质。该地区的医疗保健投资正在成长,政府致力于改善医疗保健基础设施。亚太地区呈现出多样化的市场动态,庞大的人口基数推动了消费者对视力矫正和保护的需求。用于健康监测和生活方式需求的智慧隐形眼镜越来越受欢迎,该地区的投资重点是利用製造能力来降低成本并提高可及性。
FPNV定位矩阵
FPNV 定位矩阵对于评估新一代隐形眼镜和辅助器具市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对下一代隐形眼镜和视觉辅助器具市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.下一代隐形眼镜和辅助器具市场的市场规模和预测是多少?
2.在下一代隐形眼镜和视觉辅助器具市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.下一代隐形眼镜和辅助器具市场的技术趋势和法规结构是什么?
4.下一代隐形眼镜和辅助器具市场主要供应商的市场占有率是多少?
5. 进入下一代隐形眼镜和辅助器具市场的适当型态和策略性手段是什么?
[197 Pages Report] The Next Generation Contact Lenses & Visual Prostheses Market size was estimated at USD 214.71 million in 2023 and expected to reach USD 254.45 million in 2024, at a CAGR 18.76% to reach USD 715.57 million by 2030.
Next generation contact lenses encompass a variety of advanced features and materials that enhance functionality beyond conventional vision correction. These include contact lenses designed with smart technology that may enable interactive visual overlays, health monitoring sensors, drug delivery systems, and improved comfort and vision through advanced materials or designs. Visual prostheses are medical devices designed to restore functional vision for individuals suffering from vision loss or impairment caused by conditions such as retinitis pigmentosa or age-related macular degeneration. These devices often work by bypassing damaged photoreceptors and directly stimulating the remaining functional parts of the visual system, including the retina, optic nerve, or visual cortex. Increasing an aging population, the rise in eye-related diseases, and the growing demand for non-invasive medical devices contribute to market expansion. However, high costs of development and production coupled with stringent regulatory requirements for medical device approval may impede market growth. Nevertheless, the development of smart contact lenses that monitor health indicators and the integration of AI algorithms to improve the functionality of visual prostheses with customization and 3D printing technologies to produce devices tailored to individual patients' needs is expected to create potential opportunities for the next generation contact lenses and visual prostheses market expansion.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 214.71 million |
Estimated Year [2024] | USD 254.45 million |
Forecast Year [2030] | USD 715.57 million |
CAGR (%) | 18.76% |
Product: Burgeoning adoption of therapeutic contact lenses proving invaluable in post-surgical care and treatment of various corneal conditions
Diagnostic or monitoring contact lenses are advanced ocular devices designed to measure physiological parameters, such as intraocular pressure, glucose levels, and tear composition, in a non-invasive manner. Drug-eluting contact lenses are engineered to provide a controlled release of medications directly into the eye, offering a novel approach to treating ocular conditions such as infections, allergies, and dry eyes. These lenses are impregnated with therapeutic agents and aim to improve drug contact time, enhance bioavailability, and reduce systemic side effects as compared to traditional eye drops, improving patient compliance and treatment efficacy. Therapeutic contact lenses are designed to treat and manage ocular surface disorders and injuries. They are a protective barrier over the cornea, promote healing, and can deliver drugs. Visual prostheses, or "bionic eyes," aim to restore vision to individuals with severe vision loss or blindness due to retinal diseases. These systems consist of a camera mounted on glasses, a video processing unit, and an implant that electrically stimulates the visual system. A cortical implant is a type of visual prosthesis that bypasses the eye entirely and targets the brain's visual cortex. The device translates visual information into electrical stimulation patterns delivered directly to the brain's visual cortex, intending to restore visual perception to those who have lost sight due to ocular, optic nerve, or pre-cortical visible pathway damage. An optic nerve implant is a visual prosthesis designed to stimulate the optic nerve directly, which gives visual information from the retina to the brain. This is typically considered when the retina has become non-functional; however, the nerve and downstream visual pathway remain intact. Retinal implants replace degenerated retinal cells' functionality and are primarily used to treat retinal diseases, including age-related macular degeneration and retinitis pigmentosa. These implants capture light and convert it into electrical signals, stimulating the remaining retinal cells to send visual information to the brain.
Disease: Evolving adoption of next-generation contact lenses and visual prostheses for age-related macular degeneration
Age-related macular degeneration is the foremost reason for vision loss in individuals aged 50 and above. It is characterized by the deterioration of the retina's central portion, known as the macula, which affects central vision. Advanced forms include dry and wet AMD. New generations of visual prostheses and contact lenses are being researched to amplify the remaining vision, deliver drugs to the retina to slow the progression, or even incorporate miniature cameras that interface with the neural circuitry of the retina to restore vision. Diabetic eye diseases, primarily diabetic retinopathy and diabetic macular edema, are complications of diabetes caused by damage to blood vessels in the retina. The latest advancements in contact lens technology include lenses that can monitor glucose levels through tears, potentially aiding diabetes management. Glaucoma is a cluster of eye conditions that damage the optic nerve, often linked to heightened intraocular pressure. Untreated glaucoma can lead to irreversible blindness. Contact lenses with embedded sensors are being developed to continuously monitor intraocular pressure levels, providing a non-invasive method to manage and deter glaucoma progression. Visual prostheses for glaucoma patients could be adopted to stimulate the visual pathway beyond the damaged optic nerve. Retinitis pigmentosa is a genetic disorder affecting the retina, causing gradual vision loss and night blindness. In the realm of prosthetics, significant progress has been made in creating bionic eye implants that substitute the function of degenerated photoreceptors in the retina. For contact lenses, research focuses on lenses that include microelectronics to enhance the available vision or to deliver light therapy to slow the progression of RP.
Regional Insights
The Americas region's high consumer awareness, strong economy, and insurance coverage for medical devices contribute to increased market demand. Interest in smart contact lenses with advanced features such as glucose monitoring and augmented reality has spurred several startups and R&D initiatives. Furthermore, there is an inclination towards advanced medical devices, with initiatives by both the private sector and academic institutions pushing forward innovative solutions in visual prostheses and enhanced ocular devices in the Americas. EU countries are witnessing a growing demand for advanced contact lenses due to increased activities related to digital screens and an aging populace. Regulatory directives such as the Medical Device Regulation (MDR) shape industry standards. Ongoing projects funded by the EU Framework Programmes for Research and Innovation showcase the commitment to cutting-edge ocular technology. The Middle East is gradually adopting these advanced medical devices, with a strong focus on luxury and quality. The region's healthcare investment is scaling, characterized by government initiatives to improve healthcare infrastructure. The Asia-Pacific region exhibits diverse market dynamics, with the region's large population base driving consumer needs for vision correction and protection, which is compounded by an aging demographic in certain countries. Smart contact lenses that cater to health monitoring and lifestyle needs are gaining popularity, and investments in the region are focused on leveraging manufacturing prowess to reduce costs and improve accessibility.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Next Generation Contact Lenses & Visual Prostheses Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next Generation Contact Lenses & Visual Prostheses Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Next Generation Contact Lenses & Visual Prostheses Market, highlighting leading vendors and their innovative profiles. These include ABB Optical Group, Alcon Vision LLC, Bausch & Lomb Incorporated, Bionic Vision Technologies, Chromagen Europe B.V., CooperVision, Inc., HOYA Corporation, INTEROJO CO. LTD., Johnson & Johnson Vision Care, Inc., Luneau Technology Operations SAS, Menicon Co., Ltd., Miami Contact Lens, Mojo Vision Inc., Nidek Co., Ltd., Novartis AG, Orion Vision Group, PERVICE CO., LTD., Pixium Vision SA, Sensimed SA, Spectrum International, STAAR Surgical Company, SwissLens S.A., SynergEyes, Inc., XPANCEO RESEARCH ON NATURAL SCIENCE L.L.C., and ZEISS Group.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Next Generation Contact Lenses & Visual Prostheses Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next Generation Contact Lenses & Visual Prostheses Market?
3. What are the technology trends and regulatory frameworks in the Next Generation Contact Lenses & Visual Prostheses Market?
4. What is the market share of the leading vendors in the Next Generation Contact Lenses & Visual Prostheses Market?
5. Which modes and strategic moves are suitable for entering the Next Generation Contact Lenses & Visual Prostheses Market?